Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ B7-H3 (CD276) Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5141121
This item is not returnable.
View return policy
Description
B7-H3 (CD276) Polyclonal Antibody for Western Blot, ICC/IF
CD276 is a member of the B7 family of co-stimulatory molecules also known as B7-H3. CD276 is a type I transmembrane protein that induces the proliferation of CD4+ and CD8+ T cells, enhances the generation of cytotoxic T cells and selectively stimulates the production of interferon gamma. Expression of CD276 can be induced on dendritic cells and monocytes by inflammatory cytokines, and is also widely expressed in peripheral tissues including the heart, kidney, testis and colon. In humans, CD276 exists as two isoforms which result from gene duplication and differential splicing. CD276 is reported to have therapeutic potential for the regulation of cell-mediated immune responses to cancer, particularly in conjunction with anti-angiogenic therapy.
Specifications
B7-H3 (CD276) | |
Polyclonal | |
Unconjugated | |
CD276 | |
4Ig-B7-H3; 6030411F23Rik; AU016588; B7 homolog 3; B7h3; B7-H3; B7RP-2; CD276; CD276 antigen; CD276 molecule; CD276 molecule tv1; costimulatory molecule; PSEC0249; sB7 H3; sB7H3; sCD276; soluble B7 H3; soluble B7H3; soluble CD276; UNQ309/PRO352 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
80381 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Western Blot, Immunocytochemistry, Western Blot | |
1 mg/mL | |
PBS with 0.1% BSA, 40% glycerol and 0.05% sodium azide; pH 7.4 | |
Q5ZPR3 | |
CD276 | |
Recombinant protein within human CS276 aa 1-466. | |
100 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction